Ribozymes, DNAzymes and Small Interfering RNAs as Therapeutics
Journal:
Current Drug Targets
Volume:
6
Page:
647-653
Author(s):
M. Sioud and P. O. Iversen
Decreasing the Metastatic Potential in Cancers - Targeting the Heparan Sulfate Proteoglycans
Journal:
Current Drug Targets
Volume:
6
Page:
665-682
Author(s):
K. Fjeldstad and S. O. Kolset
Assessment In Vitro of a Novel Therapeutic Strategy for Glioma, Combining Herpes Simplex Virus HSV1716-mediated Oncolysis with Gene Transfer and Targeted Radiotherapy
Journal:
Medicinal Chemistry
Volume:
1
Page:
423-429
Author(s):
M. Quigg, R. J. Mairs, S. M. Brown, J. Harland, P. Dunn, R. Rampling, A. Livingstone, L. Wilson and M. Boyd
Biology and Clinical Relevance of Mannose-Binding Lectin
Journal:
Drug Design Reviews - Online (Discontinued)
Volume:
2
Page:
457-465
Author(s):
Daniel L. Worthley, Peter G. Bardy and Charles G. Mullighan
Recent Advances in Understanding and Exploiting the Activation of Anthracyclines by Formaldehyde
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
5
Page:
431-447
Author(s):
S. M. Cutts, L. P. Swift, A. Rephaeli, A. Nudelman and D. R. Phillips
Altering the Tropism of Lentiviral Vectors through Pseudotyping
Journal:
Current Gene Therapy
Volume:
5
Page:
387-398
Author(s):
James Cronin, Xian-Yang Zhang and Jakob Reiser
Delivering RNA Interference to the Mammalian Brain
Journal:
Current Gene Therapy
Volume:
5
Page:
399-410
Author(s):
Timothy M. Fountaine, Matthew J.A. Wood and Richard Wade-Martins
The Use of Oncolytic Vaccinia Viruses in the Treatment of Cancer: A New Role for an Old Ally?
Journal:
Current Gene Therapy
Volume:
5
Page:
429-443
Author(s):
Stephen H. Thorne, David L. Bartlett and David H. Kirn
DNA Drug Design for Cancer Therapy
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
2811-2823
Author(s):
Y. S. Cho-Chung
Oligonucleotides as Anticancer Agents: From the Benchside to the Clinic and Beyond
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
2825-2840
Author(s):
F. M. Coppelli and J. R. Grandis